|
Global asthma market to reach 159 million lifetime cases by 2022
The Pharma Letter Over 300 million people suffer from asthma, which translates to a drug market worth over $15 billion. While drugs to manage asthma have existed for several decades, pharmaceutical companies have developed faster acting and more effective products over … |
View full post on asthma – Google News